The state of Texas is striving to increase cancer research capabilities and opportunities with the Cancer Prevention and Research Institute of Texas (CPRIT). One method that CPRIT uses to increase cancer research opportunities throughout the state is through the institutes core facility support awards, which provide more funding and opportunities for researchers from different Texas institutions. Recently, researchers from Texas A&M University received a $5.7 million grant from CPRIT to expand cancer research at the university through this additional core facility funding. (Image courtesy of Aggie0083 via Wikimedia Commons)Read More
Science Market Update
Does your Lab Equipment and Product Territory Include Texas?
The Texas Medical Center has recently fostered a $25 million initiative designed to support technologies and early-stage companies and to further the TMC’s mission to advance health, education and research.
"The Texas Medical Center unveiled plans for the TMC Venture Fund to an audience of more than 600 investors, hospital stakeholders, advisors and members of Houston’s innovation ecosystem" see press release. For those wondering just how big this is compared to the overall Texas Medical Center research marketplace, current estimates for the size of this market range from $1.8 Billion to $2.2 Billion.
Tags: Biotech Event, Texas Medical Center, Texas, Healthcare, tmc, Biotechnology, TX, lab equipment, Southwest Region, Biotech vendor, Lab Sales, Lab Supply, best lab supply tradeshows, best science tradeshows, BioResearch Product Faire™
In June, the Texas legislature unanimously passed Charlie’s Law which allows patients with chronic and terminal diseases access to experimental stem cell interventions. The law, named after the late Texas State representative Charlie Howard, is the first of its kind in the U.S.Read More
Tags: Stem cell research, Human Stem Cell, Texas Medical Center, Biomedical Reearch, TAMU, tmc, Biotechnology Vendor Fair, Texas A&M Research, Texas A&M Life Science Funding, biotech vendor show, Texas A&M, Research equipment, laboratory suppliers, BioResearch Product Faire, pollution
Lymphoma is one of the most common types of cancer, with Non-Hodgkin Lymphoma making up about 4% of all cancer cases in the United States, according to the American Cancer Society. Although treatment methods like chemotherapy and radiation therapy are able to treat the cancer, researchers still actively study this cancer to gain a better understanding of it to develop new targeted treatment methods.
Researchers from the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital have been studying new therapies for the cancer using T-cells, research that they will continue with the assistance of a new $11.5 million grant from the National Cancer Institute. (Image courtesy of TexasPathologistMSW ia Wikimedia Commons)Read More
Join Biotechnology Calendar, Inc. at the January Texas Medical Center BioResearch Product Faire Event and exhibit at the largest medical complex in the world.
With life science expenditures and NIH funding totaling more than 2.2 billion dollars , the BioResearch Product Faire™ offers an excellent opportunity to meet with well-funded researchers. This is further supported by consistent attendance at these trade shows well in excess of 400 researcher attendees, occasionally breaking 500 researchers in attendance.
Texas Medical Center has a new state of the art medical campus under construction which is estimated for completion in 2019 while the Zayed Building at MD Anderson just opend been opened in 2016. We invite you to join us early next year for Houston’s 18th Annual BioResearch Product Faire™.Read More
Researchers at Texas Medical Center’s (TCM) Houston Methodist Hospital have invented a way to overcome chemotherapy drug resistance and destroy the deadliest type of brain tumors without destroying the surrounding tissue. This targeted approach combines a “smart drug” with chemotherapy. In animal models of human brain cancer, this smart drug prolonged life by over six fold.Read More
Researchers at Texas Medical Center’s Rice University recently discovered that Huntington’s Disease might be triggered by a repeating nucleotide sequence in the gene for a mutant protein. The research team conducted this study by analyzing proteins that were suspected to misfold and form plaques in the brains of patients with neurological diseases.Read More
Researchers at Texas Medical Center’s McGovern School of Medicine piloted a revolutionary way of treating spina bifida patients in utero. The new method utilizes a patch made from human umbilical cord and the regenerative tissue does not cause scarring, which often leads to complications. Recent clinical trials preformed at TMC’s Fetal Center at Children’s Memorial Hermann Hospital showed improved outcomes for babies inflicted with the birth defect.
The Texas Medical Center is growing yet again, amid the imminent renovation and expansion of the Memorial Hermann-Texas Medical Center Campus. (image source: memorialhermann.org)Read More
Tags: Biomedical expansion, Medical Research, new medical facility, Texas Medical Center, Texas, Research Funding, TX, Southwest Region, new Building, research facilities, new medical buildings, 2016, BioResearch Product Faire™, Memorial Hermann
Sézary syndrome is a rare form of T-cell lymphoma that causes different types of lesions to appear on the skin once. Very little is known about the cause of this cancer, and there are no current cures available. Researchers from Baylor College of Medicine and the MD Anderson Cancer Center in Houston, Texas have identified certain genes that, when mutated, appear to play a role in Sézary syndromeRead More